Bausch Health Companies Inc. SEC filings BHC

Bausch Health Companies Inc. has 1,004 filings in SEC EDGAR's recent list, going back to May 4, 2016. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.

Bausch Health Companies Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 8, 2026 Dec 31, 2025
10-K Annual report Feb 19, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 2, 2025 Dec 31, 2024
10-K Annual report Feb 20, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 4, 2024 Dec 31, 2023
10-K Annual report Feb 22, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 6, 2023 Dec 31, 2022
10-K Annual report Feb 23, 2023 Dec 31, 2022
10-K Annual report Feb 23, 2022 Dec 31, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
10-K Annual report Feb 19, 2020 Dec 31, 2019
10-K Annual report Feb 20, 2019 Dec 31, 2018
10-K Annual report Feb 28, 2018 Dec 31, 2017
10-K Annual report Mar 1, 2017 Dec 31, 2016

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BHC (NYSE)
Fiscal year ends
December 31
Incorporated in
NJ
Headquarters
Quebec, Quebec, Canada
SEC filer status
Large accelerated filer
SEC CIK
885590
Former names
Valeant Pharmaceuticals International, Inc. (until Jul 3, 2018); BIOVAIL Corp (until Sep 27, 2010); BIOVAIL CORP INTERNATIONAL (until Apr 7, 2010); BIOVAIL CORPORATION INTERNATIONAL (until Jan 5, 2001)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.